312 related articles for article (PubMed ID: 12614146)
1. Inhibitory specificity change of the ovomucoid third domain of the silver pheasant upon introduction of an engineered Cys14-Cys39 bond.
Hemmi H; Kumazaki T; Yamazaki T; Kojima S; Yoshida T; Kyogoku Y; Katsu M; Shinohara F; Yokosawa H; Miura K; Kobayashi Y
Biochemistry; 2003 Mar; 42(9):2524-34. PubMed ID: 12614146
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional study of an Anemonia elastase inhibitor, a "nonclassical" Kazal-type inhibitor from Anemonia sulcata.
Hemmi H; Kumazaki T; Yoshizawa-Kumagaye K; Nishiuchi Y; Yoshida T; Ohkubo T; Kobayashi Y
Biochemistry; 2005 Jul; 44(28):9626-36. PubMed ID: 16008348
[TBL] [Abstract][Full Text] [Related]
3. Increasing the hydrolysis constant of the reactive site upon introduction of an engineered Cys¹⁴-Cys³⁹ bond into the ovomucoid third domain from silver pheasant.
Hemmi H; Kumazaki T; Kojima S; Yoshida T; Ohkubo T; Yokosawa H; Miura K; Kobayashi Y
J Pept Sci; 2011 Aug; 17(8):595-600. PubMed ID: 21644249
[TBL] [Abstract][Full Text] [Related]
4. Additivity-based design of the strongest possible turkey ovomucoid third domain inhibitors for porcine pancreatic elastase (PPE) and Streptomyces griseus protease B (SGPB).
Qasim MA; Wang L; Qasim S; Lu S; Lu W; Wynn R; Yi ZP; Laskowski M
FEBS Lett; 2013 Sep; 587(18):3021-6. PubMed ID: 23892073
[TBL] [Abstract][Full Text] [Related]
5. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
Bateman KS; Huang K; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
J Mol Biol; 2001 Jan; 305(4):839-49. PubMed ID: 11162096
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
7. Refined X-ray crystal structures of the reactive site modified ovomucoid inhibitor third domains from silver pheasant (OMSVP3*) and from Japanese quail (OMJPQ3*).
Musil D; Bode W; Huber R; Laskowski M; Lin TY; Ardelt W
J Mol Biol; 1991 Aug; 220(3):739-55. PubMed ID: 1870129
[TBL] [Abstract][Full Text] [Related]
8. Selective removal of individual disulfide bonds within a potato type II serine proteinase inhibitor from Nicotiana alata reveals differential stabilization of the reactive-site loop.
Schirra HJ; Guarino RF; Anderson MA; Craik DJ
J Mol Biol; 2010 Jan; 395(3):609-26. PubMed ID: 19925809
[TBL] [Abstract][Full Text] [Related]
9. The crystal and molecular structure of the third domain of silver pheasant ovomucoid (OMSVP3).
Bode W; Epp O; Huber R; Laskowski M; Ardelt W
Eur J Biochem; 1985 Mar; 147(2):387-95. PubMed ID: 3971987
[TBL] [Abstract][Full Text] [Related]
10. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
11. Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI.
Lauber T; Schulz A; Schweimer K; Adermann K; Marx UC
J Mol Biol; 2003 Apr; 328(1):205-19. PubMed ID: 12684009
[TBL] [Abstract][Full Text] [Related]
12. Crystal and molecular structures of the complex of alpha-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 A resolution.
Fujinaga M; Sielecki AR; Read RJ; Ardelt W; Laskowski M; James MN
J Mol Biol; 1987 May; 195(2):397-418. PubMed ID: 3477645
[TBL] [Abstract][Full Text] [Related]
13. Binding of amino acid side chains to preformed cavities: interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues.
Bigler TL; Lu W; Park SJ; Tashiro M; Wieczorek M; Wynn R; Laskowski M
Protein Sci; 1993 May; 2(5):786-99. PubMed ID: 8495199
[TBL] [Abstract][Full Text] [Related]
14. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
Song J; Laskowski M; Qasim MA; Markley JL
Biochemistry; 2003 Jun; 42(21):6380-91. PubMed ID: 12767219
[TBL] [Abstract][Full Text] [Related]
15. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
16. NMR determination of pKa values for Asp, Glu, His, and Lys mutants at each variable contiguous enzyme-inhibitor contact position of the turkey ovomucoid third domain.
Song J; Laskowski M; Qasim MA; Markley JL
Biochemistry; 2003 Mar; 42(10):2847-56. PubMed ID: 12627950
[TBL] [Abstract][Full Text] [Related]
17. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
Krystek S; Stouch T; Novotny J
J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional Structure of a Kunitz-type Inhibitor in Complex with an Elastase-like Enzyme.
García-Fernández R; Perbandt M; Rehders D; Ziegelmüller P; Piganeau N; Hahn U; Betzel C; Chávez Mde L; Redecke L
J Biol Chem; 2015 May; 290(22):14154-65. PubMed ID: 25878249
[TBL] [Abstract][Full Text] [Related]
19. NMR chemical shift mapping of the binding site of a protein proteinase inhibitor: changes in the (1)H, (13)C and (15)N NMR chemical shifts of turkey ovomucoid third domain upon binding to bovine chymotrypsin A(alpha).
Song J; Markley JL
J Mol Recognit; 2001; 14(3):166-71. PubMed ID: 11391787
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the non-additivity effects in the sequence-to-reactivity algorithm for serine peptidases and their inhibitors.
Lee TW; Qasim MA; Laskowski M; James MN
J Mol Biol; 2007 Mar; 367(2):527-46. PubMed ID: 17266986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
